SCHEMBL4019670

SCHEMBL4019670

N#CCCc1nccn1C(c1ccccc1)(c1ccccc1)c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.31
KCNA3 P22001 3/20 0.31
ATM Q13315 2/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
KCNN4 O15554 1/20 0.30
DRD2 P14416 1/20 0.30
DRD4 P21917 1/20 0.30
OPRM1 P35372 1/20 0.30
DRD3 P35462 1/20 0.30
EGFR P00533 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9313348 0.85 KMT2A (0.40) KMT2AMEN1CYP11B1CYP11B2SMN1; SMN2
SCHEMBL1528022 0.80 KMT2A (0.44) KMT2AMEN1CYP11B1CYP11B2SMN1; SMN2
SCHEMBL27544681 0.80 KMT2A (0.41) KMT2AMEN1CYP11B1CYP11B2SMN1; SMN2
SCHEMBL8806580 0.80 KMT2A (0.44) KMT2AMEN1CYP11B1CYP11B2SMN1; SMN2
SCHEMBL4759513 0.78 KMT2A (0.42) KMT2AMEN1CYP11B1CYP11B2
SCHEMBL8806973 0.78 KMT2A (0.42) KMT2AMEN1CYP11B1CYP11B2
SCHEMBL9229669 0.78 KMT2A (0.39) KMT2AMEN1CYP11B1CYP11B2
SCHEMBL5319750 0.77 MEN1 (0.41) KMT2AMEN1SMN1; SMN2
SCHEMBL4759621 0.77 KMT2A (0.38) KMT2AMEN1CYP11B1CYP11B2KCNA3
SCHEMBL8188378 0.76 KMT2A (0.46) KMT2AMEN1CYP11B1CYP11B2KCNA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009093981-A1 TRIAZINE COMPOUNDS AS KINASE INHIBITORS S BIO PTE LTD (SG) 2009-07-30 WO disclosed
WO-2009093981-A1 TRIAZINE COMPOUNDS AS KINASE INHIBITORS S BIO PTE LTD (SG) 2009-07-30 WO disclosed